TNF and chronic kidney disease: The highest pathway activation was observed in patients with both diabetes and CKD (Woolley et al., 2021), consistent with studies showing upregulation of the TNFα‐signaling pathway in plasma of HFpEF patients with these comorbidities, as well as with their poor clinical prognosis (Cohen et al., 2020).